Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events
1820796 / Pixabay

Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events

According to a story from Cancer Therapy Advisor, a recent study published in the journal Cancer Medicine indicated that chronic lymphocytic leukemia (CLL) patients who dealt with adverse events during treatment…

Continue Reading Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events

Patient Recruitment Completed for Phase 2 Study of Mucopolysaccharidosis VI Drug Candidate

According to a press release from the French biotechnology company Inventiva, the company has completed recruitment for a phase 2 clinical trial evaluating its experimental mucopolysaccharidosis VI drug, odiparcil. About…

Continue Reading Patient Recruitment Completed for Phase 2 Study of Mucopolysaccharidosis VI Drug Candidate
Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference
crystal710 / Pixabay

Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference

Von Willebrand disease is the most common inherited blood clotting disorder that affects humans. The disorder can also be acquired. Although it is considered common, the majority of cases do…

Continue Reading Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference
Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease
Belova59 / Pixabay

Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease

According to a story from Charcot-Marie-Tooth News, a recent study was conducted that compared the presentation of symptoms between two different variants of Charcot-Marie-Tooth disease (CMT): CMT4B1 and CMT4B2. The…

Continue Reading Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease
A New Way to Study Disease: Scientists Have Recreated a Blood-Brain Barrier Outside the Body
source: pixabay.com

A New Way to Study Disease: Scientists Have Recreated a Blood-Brain Barrier Outside the Body

  The blood-brain barrier is a “gatekeeper” that prevents toxins and foreign matter in the bloodstream from traveling to the brain. Check Orphan recently carried an article that had been…

Continue Reading A New Way to Study Disease: Scientists Have Recreated a Blood-Brain Barrier Outside the Body

Tips by a Myelodysplastic Syndromes Patient on How to Navigate the Internet When Researching Your Rare Disease

Jane Biehl Jane Biehl has worked as a professor, rehabilitation counselor, and a librarian. She holds three different degrees, and spreads her knowledge through freelance writing. She also has a…

Continue Reading Tips by a Myelodysplastic Syndromes Patient on How to Navigate the Internet When Researching Your Rare Disease
Study Confirms the Superiority of Rituximab (Rituxan) in Treating Pemphigus Vulgaris
stevepb / Pixabay

Study Confirms the Superiority of Rituximab (Rituxan) in Treating Pemphigus Vulgaris

According to a story from marketscreener.com, the biotechnology company Roche recently announced the results from a company sponsored phase 3 clinical trial that compared the safety and efficacy of rituximab…

Continue Reading Study Confirms the Superiority of Rituximab (Rituxan) in Treating Pemphigus Vulgaris

The New 5F9 Antibody Looks Encouraging as it Targets MDS and AML Leukemia in a Phase 1b Clinical Trial

  The California Institute for Regenerative Medicine (CIRM) has funded a study by a company called Forty Seven, Inc. The clinical trial is investigating the benefits of a drug therapy for two cancers…

Continue Reading The New 5F9 Antibody Looks Encouraging as it Targets MDS and AML Leukemia in a Phase 1b Clinical Trial

Scholarships are Available for the 2019 International Pain Summit Which Will be Held in LA this November

IPain The International Pain Foundation (IPain) is a nonprofit organization dedicated to supporting those with chronic pain due to neurological, musculoskeletal, inflammatory, degenerative, and emotional conditions. They aim to improve…

Continue Reading Scholarships are Available for the 2019 International Pain Summit Which Will be Held in LA this November
New Partnership Aims to Develop New Mobility Controls for Amyotrophic Lateral Sclerosis Patients
source: pixabay.com

New Partnership Aims to Develop New Mobility Controls for Amyotrophic Lateral Sclerosis Patients

According to a story from ucf.edu, a new partnership between Mayo Clinic and Limbitless Solutions is planning initiate a new clinical trial that aims to improve mobility options for patients…

Continue Reading New Partnership Aims to Develop New Mobility Controls for Amyotrophic Lateral Sclerosis Patients

The First Ever PFIC Network Family Conference will Bring Families Affected by the Disease Together This Week

Emily Ventura has never met in-person another person living with progressive familial intrahepatic cholestasis (PFIC), her daughter’s life-threatening ultra-rare genetic disease. That will change on June 21st when Emily and…

Continue Reading The First Ever PFIC Network Family Conference will Bring Families Affected by the Disease Together This Week